Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Clinical
  • Published:

Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide

British Journal of Cancer volume 86, pages 12–13 (2002)Cite this article

Abstract

Etoposide is commonly used in a variety of malignancies. A well known but rare toxicity are hypersensitivity reactions, usually manifested by chest discomfort, dyspnoea, bronchospasm and hypotension. We report the details of a patient who developed hypersensitivity reactions to intravenous etoposide, but subsequently tolerated the administration of intravenous etoposide phosphate with no sequalae.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  • Athanassiou AE, Bafaloukos D, Pectasidis D, Dimitriadis M (1988) Acute vasomotor response – a reaction to etoposide. J Clin Oncol 6: 602–603, (letter)

    Article  Google Scholar 

  • Bernstein BJ, Troner MB (1999) Successful rechallenge with etoposide phosphate after an acute hypersensitivity reaction to etoposide. Pharmacotherapy 19: 989–991

    Article  CAS  Google Scholar 

  • De Souza P, Friedlander M, Wilde C, Kristen F, Ryan M (1994) Hypersensitivity reactions to etoposide. Am J Clin Oncol 17: 387–389

    Article  CAS  Google Scholar 

  • Donegan S (1989) An unusual reaction to etoposide. Drug Intell Clin Pharm 23: 177 (letter)

    CAS  Google Scholar 

  • Eschalier A, Lavarenne J, Burtin C, Renoux M, Chapuy E, Rodriguez M (1988) Study of histamine release induced by acute administration of antitumour agents in dogs. Cancer Chemother Pharmacol 21: 246–250

    Article  CAS  Google Scholar 

  • Hoetelman RMW, Schornagel JH, Bokkeel Huinink WW, Beijnen JH (1996) Hypersensitivity reactions to etoposide. Ann Pharmacother 30: 367–371

    Article  Google Scholar 

  • Kasperek C, Black CD (1992) Two cases of suspected immunologic-based hypersensitivity reactions to etoposide therapy. Ann Pharmacother 26: 1227–1230

    Article  CAS  Google Scholar 

  • Kellie SJ, Crist WM, Pui CH, Crone ME, Fairclough DL, Rodman JH, Rivera GH (1991) Hypersensitivity reactions to epipodophyllotoxins in children with acute lymphoblastic leukaemia. Cancer 67: 1070–1075

    Article  CAS  Google Scholar 

  • O'Brien MER, Souberbielle BE (1992) Allergic reactions to cytotoxic drugs – an update. Annals Oncol 3: 605–610

    Article  CAS  Google Scholar 

  • Schacter L (1996) Etoposide phosphate: What, why, where and how? Semin Oncol 23: Suppl 13 1–7

    CAS  PubMed  Google Scholar 

  • Siderov J, Zalcberg J (1994) Safe administration of oral etoposide after hypersensitivity reaction with intravenous etoposide. Anti-Cancer Drugs 5: 602–603

    Article  CAS  Google Scholar 

  • Tester WJ, Cohn JB, Fleekop PD, Rabinowitz MS, Lieberman JS (1990) Successful rechallenge to etoposide after an acute vasomotor response. J Clin Oncol 8: 1600–1601, (letter)

    Article  CAS  Google Scholar 

  • Tucci E, Pirtoli L (1985) Etoposide-induced hypersensitivity reactions. Chemotherapia 4: 460–462

    CAS  Google Scholar 

  • Weiss RB (1996) Hypersensitivity reactions. In The chemotherapy source book Perry MC (ed) 2nd edn pp 613–634, Baltimore: Williams & Wilkins

    Google Scholar 

  • Williams S, Birch R, Einhorn L, Irwin L, Greco FA, Loehrer PJ (1987) Treatment of disseminated germ cell tumours with cisplatin, bleomycin and either vinblastine or etoposide. N Engl J Med 316: 1435–1440

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pharmacy Department, Austin & Repatriation Medical Centre, Studley Road, Heidelberg, 3084, Australia

    J Siderov & P Prasad

  2. Cancer Services, Austin & Repatriation Medical Centre, Studley Road, Heidelberg, 3084, Australia

    R De Boer & J Desai

Authors
  1. J Siderov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Prasad
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R De Boer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J Desai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J Siderov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Siderov, J., Prasad, P., De Boer, R. et al. Safe administration of etoposide phosphate after hypersensitivity reaction to intravenous etoposide. Br J Cancer 86, 12–13 (2002). https://doi.org/10.1038/sj.bjc.6600003

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bjc.6600003

Keywords

This article is cited by

Search

Advanced search

Quick links